BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 28445539)

  • 1. Restless legs syndrome and cardiovascular diseases: A case-control study.
    Cholley-Roulleau M; Chenini S; Béziat S; Guiraud L; Jaussent I; Dauvilliers Y
    PLoS One; 2017; 12(4):e0176552. PubMed ID: 28445539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of restless legs syndrome and cardiovascular disease in the Sleep Heart Health Study.
    Winkelman JW; Shahar E; Sharief I; Gottlieb DJ
    Neurology; 2008 Jan; 70(1):35-42. PubMed ID: 18166705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Cardiovascular Disease Associated with a Restless Legs Syndrome Diagnosis in a Retrospective Cohort Study from Kaiser Permanente Northern California.
    Van Den Eeden SK; Albers KB; Davidson JE; Kushida CA; Leimpeter AD; Nelson LM; Popat R; Tanner CM; Bibeau K; Quesenberry CP
    Sleep; 2015 Jul; 38(7):1009-15. PubMed ID: 26083613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Cardiovascular Risk Factors and Restless Legs Syndrome in Women and Men: A Preliminary Population-Based Study in China.
    Liu Y; Liu G; Li L; Yang J; Ma S
    J Clin Sleep Med; 2018 Mar; 14(3):445-450. PubMed ID: 29458704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between restless legs syndrome and hypertension: a preliminary population-based study in South Tyrol, Italy.
    Giannini G; Zanigni S; Melotti R; Gögele M; Provini F; Facheris MF; Cortelli P; Pramstaller PP
    Eur J Neurol; 2014; 21(1):72-8. PubMed ID: 23906194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excessive Daytime sleepiness in idiopathic restless legs syndrome: characteristics and evolution under dopaminergic treatment.
    Kallweit U; Siccoli MM; Poryazova R; Werth E; Bassetti CL
    Eur Neurol; 2009; 62(3):176-9. PubMed ID: 19602890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A time sequence analysis of the relationship between cardiovascular risk factors, vascular diseases and restless legs syndrome in the general population.
    Szentkirályi A; Völzke H; Hoffmann W; Happe S; Berger K
    J Sleep Res; 2013 Aug; 22(4):434-42. PubMed ID: 23374090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sudden onset of sleep and dopaminergic therapy in patients with restless legs syndrome.
    Möller JC; Körner Y; Cassel W; Meindorfner C; Krüger HP; Oertel WH; Stiasny-Kolster K
    Sleep Med; 2006 Jun; 7(4):333-9. PubMed ID: 16554184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between Restless Legs Syndrome Symptoms and Self-Reported Hypertension: a Nationwide Questionnaire Study in Korea.
    Sunwoo JS; Kim WJ; Chu MK; Yang KI
    J Korean Med Sci; 2019 Apr; 34(16):e130. PubMed ID: 31020817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship among restless legs syndrome (Willis-Ekbom Disease), hypertension, cardiovascular disease, and cerebrovascular disease.
    Ferini-Strambi L; Walters AS; Sica D
    J Neurol; 2014 Jun; 261(6):1051-68. PubMed ID: 23963470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcome after acute ischaemic stroke: the influence of restless legs syndrome.
    Medeiros CA; de Bruin PF; Paiva TR; Coutinho WM; Ponte RP; de Bruin VM
    Eur J Neurol; 2011 Jan; 18(1):144-9. PubMed ID: 20528909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of cabergoline in restless legs syndrome: a placebo-controlled study with polysomnography (CATOR).
    Oertel WH; Benes H; Bodenschatz R; Peglau I; Warmuth R; Happe S; Geisler P; Cassel W; Leroux M; Kohnen R; Stiasny-Kolster K
    Neurology; 2006 Sep; 67(6):1040-6. PubMed ID: 16931508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of impact of insomnia on depression and quality of life in restless legs syndrome/Willis-Ekbom disease and primary insomnia patients.
    Song ML; Oldham MA; Park KM; Lee ES; Lee HB; Cho YW
    Sleep Med; 2015 Nov; 16(11):1403-1408. PubMed ID: 26498243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute.
    García-Borreguero D; Allen RP; Kohnen R; Högl B; Trenkwalder C; Oertel W; Hening WA; Paulus W; Rye D; Walters A; Winkelmann J; Earley CJ;
    Sleep Med; 2007 Aug; 8(5):520-30. PubMed ID: 17544323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The urge to move and breathe - the impact of obstructive sleep apnea syndrome treatment in patients with previously diagnosed, clinically significant restless legs syndrome.
    Silva C; Peralta AR; Bentes C
    Sleep Med; 2017 Oct; 38():17-20. PubMed ID: 29031750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation of the International Restless Legs Syndrome Study Group rating scale with the Clinical Global Impression severity scale, the restless legs syndrome 6-item questionnaire, and the restless legs syndrome-quality of life questionnaire.
    Allen R; Oertel W; Walters A; Benes H; Schollmayer E; Grieger F; Moran K; Kohnen R
    Sleep Med; 2013 Dec; 14(12):1375-80. PubMed ID: 24246378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silent Cerebral Small Vessel Disease in Restless Legs Syndrome.
    Ferri R; Cosentino FI; Moussouttas M; Lanuzza B; Aricò D; Bagai K; Wang L; McLaughlin B; Walters AS
    Sleep; 2016 Jul; 39(7):1371-7. PubMed ID: 27091527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between restless leg syndrom and slow coronary flow.
    Erden İ; Çakcak Erden E; Durmuş H; Tıbıllı H; Tabakçı M; Kalkan ME; Türker Y; Akçakoyun M
    Anadolu Kardiyol Derg; 2014 Nov; 14(7):612-6. PubMed ID: 25036324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nocturnal eating is part of the clinical spectrum of restless legs syndrome and an underestimated risk factor for increased body mass index.
    Antelmi E; Vinai P; Pizza F; Marcatelli M; Speciale M; Provini F
    Sleep Med; 2014 Feb; 15(2):168-72. PubMed ID: 24394729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognitive function in patients with idiopathic Restless Legs Syndrome before and after treatment with dopamine-agonist.
    Galbiati A; Marelli S; Giora E; Zucconi M; Oldani A; Ferini-Strambi L
    Int J Psychophysiol; 2015 Mar; 95(3):304-9. PubMed ID: 25514234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.